Significant Ownership of Mark E. Strome
- Signature - Title
- /s/ Mark E. Strome - Mark E. Strome
- Location
- Santa Monica, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Mark E. Strome.
Follow Filing Activity
Follow Mark E. Strome and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Mark E. Strome
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience, Inc. | Common Stock, par value $.001 per share | 12% | $53,142 | 442,854 | Mark E. Strome | 26 Dec 2024 | ||
| ZIVO | Zivo Bioscience | Common Stock, par value $.001 per share | 12% | 472,942 | Mark E. Strome | 31 Dec 2025 | |||
| CUE | Cue Biopharma, Inc. | Common Stock, $0.001 par value per share | 5% | $1,862,968 | 2,166,242 | Mark E. Strome | 14 Nov 2022 |
Schedules 13D/G Reported by Mark E. Strome:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.